ANTIGENIC PEPTIDES FOR CANCER PREVENTION AND TREATMENT

Abstract

The present invention relates to antigen-based immunotherapy, particularly cancer immunotherapy. In particular, the present invention provides antigenic peptides, which are distinct from, but have amino acid similarity to, human tumor antigen fragments. The present invention further provides immunogenic compounds, nanoparticles, cells and pharmaceutical compositions comprising such antigenic peptides and nucleic acids encoding such antigenic peptides.